COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

Patients with obesity have more orbital fat expansion, which, in the setting of thyroid eye disease, can lead to more severe proptosis, according to research published in BMC Ophthalmology . The study ...

The trial confirmed linsitinib's favorable safety profile, with no QTc prolongation and manageable adverse events. Late-stage ...

Topline results have been announced from a Phase 2/3 trial assessing linsitinib for the treatment of active, moderate to ...

Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release ...

Stress is an inevitable part of filmmaking, but how you manage it matters. When stress builds, it can hinder creativity and ...

The US company has said that its treatment for Thyroid Eye Disease saw a statistically significant reduction in the symptoms ...

TED is a rare autoimmune disorder in which the muscles and fatty tissues behind the eye become inflamed, causing the eyes to ...

Linsitinib is an oral small molecule that inhibits the activity of insulin-like growth factor-1 receptor (IGF-1R). It is believed that inhibition of IGF-1R may help reduce orbital inflammation and ...

US late-stage biopharma firm Sling Therapeutics today announced top-line efficacy and safety data from the Phase IIb/III LIDS ...

Sling Therapeutics’ oral challenger to Amgen’s intravenous Tepezza has hit the mark in a phase 2b/3 thyroid eye disease (TED) ...

Soleo Health, a leader and national provider of complex specialty pharmacy services, announced Jan. 7 the opening of its new ...